Radiation boosts targeted therapy in Tough-to-Treat lymphoma
Disease control
Recruiting now
This study tests whether adding a short course of radiation to the drug glofitamab can help people with a fast-growing type of lymphoma (DLBCL) that has come back or not responded to prior treatment. It focuses on patients with a high tumor burden, who typically do not respond as…
Phase: PHASE2 • Sponsor: Liling Zhang • Aim: Disease control
Last updated May 17, 2026 07:35 UTC